Showing results (201-210 of 356) with videos related to

Sort By:
Pageof 36
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1992
Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a new renin inhibitor). I: Single dose studyS K Gupta, G R Granneman, R S Boger, et al.
The Journal of Clinical Investigation|December 1, 1994
Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertensionC L Gaboury, D C Simonson, E W Seely, et al.
AJNR. American Journal of Neuroradiology|November 1, 1990
Cocaine- and methamphetamine-induced acute cerebral vasospasm: an angiographic study in rabbitsA M Wang, J N Suojanen, V M Colucci, et al.
American Journal of Hypertension|May 1, 1997
Renal sodium pump regulation in deoxycorticosterone salt hypertension in the ratP A Soszynski, Q F Tao, H H Krep, et al.
American Journal of Hypertension|June 1, 1990
Dopamine and nonmodulating hypertensionG H Williams, M S Gordon, C A Stuenkel, et al.
Kidney International|March 7, 2001
Renal perfusion and function in healthy African AmericansD A Price, N D Fisher, S Y Osei, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1989
The role of dopamine in nonmodulating hypertensionM S Gordon, C A Steunkel, P R Conlin, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 31, 1998
A labile sodium pump inhibitor from the peritoneal dialysate of hypertensive renal failure patients: estimates of potencyS W Graves, Q F Tao, K E Markides, et al.
Hypertension (Dallas, Tex. : 1979)|September 18, 1999
Altered adrenal sensitivity to angiotensin II in low-renin essential hypertensionN D Fisher, S Hurwitz, C Ferri, et al.
The Journal of Clinical Investigation|March 1, 1979
The adrenal receptor for angiotensin II is altered in essential hypertensionG H Williams, N K Hollenberg, T J Moore, et al.
Pageof 36